Wells Fargo & Company Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN) had its price target reduced by Wells Fargo & Company from $56.00 to $42.00 in a report released on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target points to a potential upside of 21.05% from the company’s previous close.

Other analysts also recently issued reports about the stock. Cantor Fitzgerald cut their price target on shares of Ryan Specialty from $45.00 to $40.00 and set a “neutral” rating on the stock in a research report on Thursday. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $55.00 to $49.00 and set an “outperform” rating on the stock in a research report on Tuesday. Citigroup cut their price target on shares of Ryan Specialty from $60.00 to $55.00 and set a “buy” rating on the stock in a research report on Monday, March 23rd. BMO Capital Markets downgraded shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and dropped their target price for the stock from $66.00 to $43.00 in a report on Wednesday, February 25th. Finally, Royal Bank Of Canada started coverage on shares of Ryan Specialty in a report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $51.25.

Ryan Specialty Trading Down 0.6%

Shares of NYSE:RYAN traded down $0.22 during mid-day trading on Thursday, reaching $34.70. The stock had a trading volume of 100,984 shares, compared to its average volume of 2,061,570. The firm has a market cap of $9.17 billion, a PE ratio of 82.63, a price-to-earnings-growth ratio of 0.88 and a beta of 0.71. The firm has a 50 day simple moving average of $38.73 and a two-hundred day simple moving average of $48.64. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty has a twelve month low of $31.50 and a twelve month high of $75.26.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings results on Thursday, February 12th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The firm had revenue of $751.21 million during the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The business’s revenue was up 13.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.45 earnings per share. On average, research analysts predict that Ryan Specialty will post 2.29 EPS for the current fiscal year.

Insider Buying and Selling

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the firm’s stock in a transaction dated Monday, February 23rd. The stock was bought at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the purchase, the director directly owned 428,295 shares of the company’s stock, valued at $17,114,668.20. The trade was a 6.33% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 52.21% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Several hedge funds have recently made changes to their positions in RYAN. Los Angeles Capital Management LLC bought a new position in shares of Ryan Specialty during the 4th quarter worth approximately $25,000. Advisory Services Network LLC bought a new position in shares of Ryan Specialty during the 3rd quarter worth approximately $28,000. SBI Securities Co. Ltd. grew its stake in shares of Ryan Specialty by 6,322.2% during the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company’s stock worth $30,000 after acquiring an additional 569 shares in the last quarter. Fifth Third Bancorp grew its stake in shares of Ryan Specialty by 65.4% during the 3rd quarter. Fifth Third Bancorp now owns 612 shares of the company’s stock worth $34,000 after acquiring an additional 242 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. grew its stake in shares of Ryan Specialty by 83.7% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company’s stock worth $35,000 after acquiring an additional 273 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Ryan Specialty News Summary

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: UBS lowered its price target from $65 to $59 but kept a “Buy” rating, implying roughly 69% upside versus the current share price. UBS lowers price target to $59
• Positive Sentiment: Goldman Sachs cut its target from $57 to $49 but retained a “Buy” rating, leaving an estimated ~41% upside from current levels. Goldman lowers PT to $49
• Positive Sentiment: Barclays trimmed its target to $41 (from $45) while keeping an “Overweight” view, signaling continued confidence though with more modest upside (~18%). Barclays lowers PT to $41
• Positive Sentiment: Keefe, Bruyette & Woods lowered its target to $49 and maintained an “Outperform” stance, preserving a sizable implied upside. Keefe, Bruyette & Woods lowers PT to $49
• Neutral Sentiment: Morgan Stanley also reduced its price target to $50; the move signals more cautious assumptions but did not result in a clear sell stance. Morgan Stanley lowers PT to $50
• Neutral Sentiment: An analysts round‑up piece summarized views on Ryan Specialty alongside other financials — useful context but not a direct catalyst. Analysts offer insights on Ryan Specialty
• Negative Sentiment: Aggregate effect: multiple simultaneous price‑target downgrades compress short‑term sentiment — that collective downward revision pressure is the most likely driver of the stock’s decline today. Coverage: multiple PT cuts

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.